Current role
Biotechnology · Healthcare
Board Member
2025-11-06–present
Roger Dansey, M.D.
Board Member
Nurix Therapeutics, Inc. (NRIX)Equibles does not estimate personal net worth.
Get an email with a short summary when Nurix Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NRIX alertsAbout Roger Dansey, M.D.
Roger Dansey, M.D. is recorded as Board Member at Nurix Therapeutics, Inc. (NRIX) since November 6, 2025. Nurix Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Roger Dansey, M.D. was appointed director, effective November 6, 2025. Nurix Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nurix Therapeutics, Inc. includes Arthur T. Sands (CEO and Board Member), Hans van Houte (CFO), Stefani Wolff (COO) and 7 others.
“On November 6, 2025, the board of directors (the "Board") of Nurix Therapeutics, Inc. (the "Company"), following a recommendation from the Nominating and Corporate Governance Committee of the Board, appointed Roger Dansey, M.D., to serve as a director of the Company and as a member of the Clinical and Commercialization Committee of the Board (the "Clinical and Commercialization Committee"), effective immediately.”
Affiliation history
-
Current
2025-11-06–present
Company network
Leadership on record at Nurix Therapeutics, Inc.
- Arthur T. Sands CEO, Board Member
- Hans van Houte CFO
- Stefani Wolff COO
- Christine Ring General Counsel
- Anil Kapur Board Member
- Clay B. Siegall, Ph.D. Board Member
- Edward C. Saltzman Board Member
- Judith A. Reinsdorf Board Member
- Paul M. Silva Board Member
- Roy D. Baynes, MB.Bch., M.Med., Ph.D. Board Member